3 active not recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 3 |
Follow Rhinitis, Allergic: new trials by email Literature Review of Rhinitis, Allergic trials Research Report on Rhinitis, Allergic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study Evaluating the Efficacy and Safety of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis SHR-1819 Injection, SHR-1819 Injection Placebo - Seasonal Allergic Rhinitis | Phase 3 | Active not recruiting | Guangdong Hengrui Pharmaceutical Co., Ltd | 220 | 2026-08-11 | 2026-10-22 |
| Efficacy and Safety of LP-003 Injection in Patients With Moderate to Severe Seasonal Allergic Rhinitis LP-003, Placebo - Seasonal Allergic Rhinitis | Phase 3 | Active not recruiting | Longbio Pharma | 546 | 2024-08-01 | 2025-12-26 |
| A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1) LY3650150, Placebo, Standard therapy for INCS - Perennial Allergic Rhinitis (PAR) | Phase 3 | Active not recruiting | Eli Lilly and Company | 450 | 2024-04-26 | 2026-10-27 |
Rhinitis, Allergic, Seasonal (2) · Rhinitis, Allergic, Perennial (1)
Hypersensitivity (3) · Hypersensitivity, Immediate (3) · Immune System Diseases (3) · Nose Diseases (3) · Otorhinolaryngologic Diseases (3) · Respiratory Hypersensitivity (3) · Respiratory Tract Diseases (3) · Rhinitis (3)
Standard of Care (1)
Eli Lilly and Company (1) · Guangdong Hengrui Pharmaceutical Co., Ltd (1) · Longbio Pharma (1)
China (3) · Belgium (1) · Germany (1) · Poland (1) · South Korea (1) · United States (1)
Xueyan Wang (1)
2023 (1)